Baxter International Inc. (NYSE: BAX) is set to break up into two companies on or around ... The mid 2015 spin is a catalyst for the stock. Post-spin, we believe the medical products (New Baxter) has the most opportunity given margin …
Government-owned Deutsche Bahn, which is preparing for its eventual privatization, said BAX Global is a good fit with the ... Brink's shares fell 18 cents to $47.80 in afternoon trading on the New York Stock Exchange, but are still near the …
For a hedged play on Baxter International (BAX) MarketIntelligenceCenter.com’s patented trade-picking algorithms selected a May 18, 2018 $67.50 covered call for a net debit in the $65 area. That is also the break-even stock price for …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BAX at https://www.zacks.com/ap/BAX
LivingSocial is engaged in serious talks to sell its Korean deals business Ticket Monster ... In a carefully worded statement, LivingSocial CFO John Bax said this week that a deal had not been reached, but little else. Bax said that …
BAX). Halozyme has royalty terms in place with companies interested in using ENHANZE, making the technology a major revenue driver going forward. Halozyme's stock lost half its value when the FDA voiced concerns about the safety of the …
DEERFIELD (dpa-AFX) - Healthcare company Baxter International Inc (BAX) on Friday said its board has approved ... dividend of 80.5 percent of the outstanding shares of Baxalta common stock. Baxter will retain a 19.5 percent …
Marissa Mayer's stock surged 4.51% on a day sisters showed Mister Market ... aerospace outfit is initiated with a Buy at Drexel Hamilton. Baxter International Inc. (BAX): Credit Suisse covers the medical device maker at Outperform. …
CHICAGO, Oct 18 (Reuters) - Baxter International Inc (BAX.N) on Thursday posted better-than-expected ... put investor concerns to rest and reaffirm our bullish view on the stock,” Morgan Stanley analyst Glenn Reicin wrote in a research note.